NYSE - Delayed Quote USD

Waters Corporation (WAT)

308.35 -1.90 (-0.61%)
At close: April 25 at 4:00 PM EDT
308.30 -0.05 (-0.02%)
After hours: April 25 at 5:05 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Udit Batra Ph.D. President, CEO & Director 1.17M -- 1971
Mr. Amol Chaubal Senior VP & CFO 635.66k -- 1977
Ms. Jianqing Y. Bennett Senior Vice President of TA Instruments Division & Waters Clinical Business Unit 621.09k -- 1970
Mr. Christos Ross Senior VP of Global Operations & Interim Senior VP of the Waters Division -- -- --
Caspar Tudor Director of Investor Relations -- -- --
Ms. Keeley A. Aleman Senior VP, General Counsel & Corporate Secretary 897.33k -- 1977
Ms. Kristen Garvey Vice President of Corporate Communications -- -- --
Mr. Patrick Conway Interim Vice President of Human Resources -- -- --
Dr. Daniel Rush Ph.D. Senior Vice President of Strategy & Transformation -- -- --
John Lynch Treasurer -- -- --

Waters Corporation

34 Maple Street
Milford, MA 01757
United States
508 478 2000 https://www.waters.com
Sector: 
Healthcare
Full Time Employees: 
7,900

Description

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Corporate Governance

Waters Corporation’s ISS Governance QualityScore as of April 1, 2024 is 4. The pillar scores are Audit: 4; Board: 4; Shareholder Rights: 4; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 07, 2024
Waters Corporation Earnings Call

Related Tickers

MTD Mettler-Toledo International Inc.
1,232.91
-0.20%
 
A Agilent Technologies, Inc.
136.37
-0.81%
 
IDXX IDEXX Laboratories, Inc.
489.24
-1.02%
 
CRL Charles River Laboratories International, Inc.
227.81
-4.85%
 
IQV IQVIA Holdings Inc.
233.98
-2.85%
 
MEDP Medpace Holdings, Inc.
389.77
-1.96%
 
TMO Thermo Fisher Scientific Inc.
571.73
-0.98%
 
LH Laboratory Corporation of America Holdings
198.35
-4.61%
 
ICLR ICON Public Limited Company
300.08
-3.02%
 
DHR Danaher Corporation
245.80
-1.84%